Stay updated on Clinical Trial: Fixed Dose Triple Therapy for Severe COPD
Sign up to get notified when there's something new on the Clinical Trial: Fixed Dose Triple Therapy for Severe COPD page.

Latest updates to the Clinical Trial: Fixed Dose Triple Therapy for Severe COPD page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe page now displays the ClinicalTrials.gov record for the completed TRIVOLVE study of fixed-dose triple therapy for chronic obstructive pulmonary disease. It includes study details, participant criteria, Belgian locations, and measured outcomes.SummaryDifference46%

- Check15 days agoChange DetectedThe footer revision label changes from v3.7.2 to v3.8.0; the study record remains inaccessible behind a 403 error.SummaryDifference0.2%

- Check22 days agoChange DetectedA sitewide notice was added announcing an NIH website transition and explaining that both “Super Intelligence” and “Artificial Intelligence” may appear during the transition.SummaryDifference1%

- Check29 days agoChange DetectedThe footer revision number changes from v3.7.1 to v3.7.2 while the page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check36 days agoChange DetectedThe site footer revision identifier changes from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check43 days agoChange DetectedThe 403 Forbidden message and its Home button are gone, leaving the area beneath the breadcrumb blank.SummaryDifference0.5%

Stay in the know with updates to Clinical Trial: Fixed Dose Triple Therapy for Severe COPD
Enter your email address, and we'll notify you when there's something new on the Clinical Trial: Fixed Dose Triple Therapy for Severe COPD page.